{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T03:50:44Z","timestamp":1794109844245,"version":"4.8.0"},"reference-count":176,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T00:00:00Z","timestamp":1753315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T00:00:00Z","timestamp":1753315200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Urol"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1038\/s41585-025-01066-y","type":"journal-article","created":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T10:16:34Z","timestamp":1753352194000},"page":"70-88","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Mechanisms and implications of epithelial cell plasticity in the bladder"],"prefix":"10.1038","volume":"23","author":[{"given":"Kan","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiapeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianding","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6145-7045","authenticated-orcid":false,"given":"Xiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6787-0495","authenticated-orcid":false,"given":"Chong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,24]]},"reference":[{"key":"1066_CR1","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1152\/physrev.00030.2012","volume":"93","author":"L Birder","year":"2013","unstructured":"Birder, L. & Andersson, K. E. Urothelial signaling. Physiol. Rev. 93, 653\u2013680 (2013).","journal-title":"Physiol. Rev."},{"key":"1066_CR2","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1007\/s00467-021-05239-w","volume":"37","author":"AR Jackson","year":"2022","unstructured":"Jackson, A. R., Narla, S. T., Bates, C. M. & Becknell, B. Urothelial progenitors in development and repair. Pediatr. Nephrol. 37, 1721\u20131731 (2022).","journal-title":"Pediatr. Nephrol."},{"key":"1066_CR3","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s10555-015-9589-6","volume":"34","author":"M Garg","year":"2015","unstructured":"Garg, M. Urothelial cancer stem cells and epithelial plasticity: current concepts and therapeutic implications in bladder cancer. Cancer Metastasis Rev. 34, 691\u2013701 (2015).","journal-title":"Cancer Metastasis Rev."},{"key":"1066_CR4","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.diff.2016.10.001","volume":"95","author":"B Al-Kurdi","year":"2017","unstructured":"Al-Kurdi, B. Hierarchical transcriptional profile of urothelial cells development and differentiation. Differentiation 95, 10\u201320 (2017).","journal-title":"Differentiation"},{"key":"1066_CR5","first-page":"103","volume":"167","author":"SP Jost","year":"1989","unstructured":"Jost, S. P., Gosling, J. A. & Dixon, J. S. The morphology of normal human bladder urothelium. J. Anat. 167, 103\u2013115 (1989).","journal-title":"J. Anat."},{"key":"1066_CR6","doi-asserted-by":"publisher","first-page":"F242","DOI":"10.1152\/ajprenal.00307.2001","volume":"283","author":"J Lavelle","year":"2002","unstructured":"Lavelle, J. et al. Bladder permeability barrier: recovery from selective injury of surface epithelial cells. Am. J. Physiol. Ren. Physiol. 283, F242\u2013F253 (2002).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"1066_CR7","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1097\/MOT.0000000000000084","volume":"19","author":"T Yamany","year":"2014","unstructured":"Yamany, T., Van Batavia, J. & Mendelsohn, C. Formation and regeneration of the urothelium. Curr. Opin. Organ Transplant. 19, 323\u2013330 (2014).","journal-title":"Curr. Opin. Organ Transplant."},{"key":"1066_CR8","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1089\/ten.tea.2013.0394","volume":"20","author":"F Wezel","year":"2014","unstructured":"Wezel, F., Pearson, J. & Southgate, J. Plasticity of in vitro-generated urothelial cells for functional tissue formation. Tissue Eng. Part A 20, 1358\u20131368 (2014).","journal-title":"Tissue Eng. Part A"},{"key":"1066_CR9","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13007","volume":"54","author":"Y Li","year":"2021","unstructured":"Li, Y. et al. Single-cell transcriptomes of mouse bladder urothelium uncover novel cell type markers and urothelial differentiation characteristics. Cell Prolif. 54, e13007 (2021).","journal-title":"Cell Prolif."},{"key":"1066_CR10","doi-asserted-by":"publisher","first-page":"1242281","DOI":"10.1126\/science.1242281","volume":"344","author":"C Blanpain","year":"2014","unstructured":"Blanpain, C. & Fuchs, E. Stem cell plasticity. Plasticity of epithelial stem cells in tissue regeneration. Science 344, 1242281 (2014).","journal-title":"Science"},{"key":"1066_CR11","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202051921","volume":"22","author":"A Tata","year":"2021","unstructured":"Tata, A., Chow, R. D. & Tata, P. R. Epithelial cell plasticity: breaking boundaries and changing landscapes. EMBO Rep. 22, e51921 (2021).","journal-title":"EMBO Rep."},{"key":"1066_CR12","doi-asserted-by":"publisher","first-page":"5605","DOI":"10.3390\/cancers15235605","volume":"15","author":"MN Wicker","year":"2023","unstructured":"Wicker, M. N. & Wagner, K. U. Cellular plasticity in mammary gland development and breast cancer. Cancers 15, 5605 (2023).","journal-title":"Cancers"},{"key":"1066_CR13","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1046\/j.1432-0436.2000.660207.x","volume":"66","author":"Y Li","year":"2000","unstructured":"Li, Y., Liu, W., Hayward, S. W., Cunha, G. R. & Baskin, L. S. Plasticity of the urothelial phenotype: effects of gastro-intestinal mesenchyme\/stroma and implications for urinary tract reconstruction. Differentiation 66, 126\u2013135 (2000).","journal-title":"Differentiation"},{"key":"1066_CR14","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1007\/s11255-021-02942-3","volume":"53","author":"CL Dunton","year":"2021","unstructured":"Dunton, C. L., Purves, J. T., Hughes, F. M. Jr. & Nagatomi, J. BOO induces fibrosis and EMT in urothelial cells which can be recapitulated in vitro through elevated storage and voiding pressure cycles. Int. Urol. Nephrol. 53, 2007\u20132018 (2021).","journal-title":"Int. Urol. Nephrol."},{"key":"1066_CR15","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1681\/ASN.2019040335","volume":"30","author":"Z Yu","year":"2019","unstructured":"Yu, Z. et al. Single-cell transcriptomic map of the human and mouse bladders. J. Am. Soc. Nephrol. 30, 2159\u20132176 (2019).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1066_CR16","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1038\/s43018-023-00595-y","volume":"4","author":"A P\u00e9rez-Gonz\u00e1lez","year":"2023","unstructured":"P\u00e9rez-Gonz\u00e1lez, A., B\u00e9vant, K. & Blanpain, C. Cancer cell plasticity during tumor progression, metastasis and response to therapy. Nat. Cancer 4, 1063\u20131082 (2023).","journal-title":"Nat. Cancer"},{"key":"1066_CR17","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1158\/2159-8290.CD-23-0225","volume":"13","author":"A Davies","year":"2023","unstructured":"Davies, A., Zoubeidi, A., Beltran, H. & Selth, L. A. The transcriptional and epigenetic landscape of cancer cell lineage plasticity. Cancer Discov. 13, 1771\u20131788 (2023).","journal-title":"Cancer Discov."},{"key":"1066_CR18","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.semcancer.2018.08.009","volume":"53","author":"V da Silva-Diz","year":"2018","unstructured":"da Silva-Diz, V., Lorenzo-Sanz, L., Bernat-Peguera, A., Lopez-Cerda, M. & Mu\u00f1oz, P. Cancer cell plasticity: impact on tumor progression and therapy response. Semin. Cancer Biol. 53, 48\u201358 (2018).","journal-title":"Semin. Cancer Biol."},{"key":"1066_CR19","doi-asserted-by":"publisher","first-page":"dev.198184","DOI":"10.1242\/dev.198184","volume":"149","author":"GB Wiessner","year":"2022","unstructured":"Wiessner, G. B., Plumber, S. A., Xiang, T. & Mendelsohn, C. L. Development, regeneration and tumorigenesis of the urothelium. Development 149, dev.198184 (2022).","journal-title":"Development"},{"key":"1066_CR20","doi-asserted-by":"publisher","first-page":"260","DOI":"10.4252\/wjsc.v8.i8.260","volume":"8","author":"M Garg","year":"2016","unstructured":"Garg, M. Epithelial plasticity in urothelial carcinoma: current advancements and future challenges. World J. Stem Cell 8, 260\u2013267 (2016).","journal-title":"World J. Stem Cell"},{"key":"1066_CR21","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/j.ccell.2022.08.010","volume":"40","author":"M Wang","year":"2022","unstructured":"Wang, M. et al. Acquired semi-squamatization during chemotherapy suggests differentiation as a therapeutic strategy for bladder cancer. Cancer Cell 40, 1044\u20131059 (2022).","journal-title":"Cancer Cell"},{"key":"1066_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34251-3","volume":"13","author":"JI Warrick","year":"2022","unstructured":"Warrick, J. I. et al. FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiation. Nat. Commun. 13, 6575 (2022).","journal-title":"Nat. Commun."},{"key":"1066_CR23","volume":"7","author":"M Garioni","year":"2023","unstructured":"Garioni, M. et al. Patient-derived organoids identify tailored therapeutic options and determinants of plasticity in sarcomatoid urothelial bladder cancer. npj\u00a0Precis. Oncol. 7, 112 (2023).","journal-title":"npj\u00a0Precis. Oncol."},{"key":"1066_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16162-3","volume":"11","author":"JP Sfakianos","year":"2020","unstructured":"Sfakianos, J. P. et al. Epithelial plasticity can generate multi-lineage phenotypes in human and murine bladder cancers. Nat. Commun. 11, 2540 (2020).","journal-title":"Nat. Commun."},{"key":"1066_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114146","volume":"43","author":"S Lee","year":"2024","unstructured":"Lee, S. et al. Loss of LPAR6 and CAB39L dysregulates the basal-to-luminal urothelial differentiation program, contributing to bladder carcinogenesis. Cell Rep. 43, 114146 (2024).","journal-title":"Cell Rep."},{"key":"1066_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12307-1","volume":"10","author":"CP Santos","year":"2019","unstructured":"Santos, C. P. et al. Urothelial organoids originating from Cd49f(high) mouse stem cells display Notch-dependent differentiation capacity. Nat. Commun. 10, 4407 (2019).","journal-title":"Nat. Commun."},{"key":"1066_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11914","volume":"7","author":"G Papafotiou","year":"2016","unstructured":"Papafotiou, G. et al. KRT14 marks a subpopulation of bladder basal cells with pivotal role in regeneration and tumorigenesis. Nat. Commun. 7, 11914 (2016).","journal-title":"Nat. Commun."},{"key":"1066_CR28","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.celrep.2018.09.042","volume":"25","author":"J Wang","year":"2018","unstructured":"Wang, J. et al. Polyploid superficial cells that maintain the urothelial barrier are produced via incomplete cytokinesis and endoreplication. Cell Rep. 25, 464\u2013477 (2018).","journal-title":"Cell Rep."},{"key":"1066_CR29","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/nature09851","volume":"472","author":"K Shin","year":"2011","unstructured":"Shin, K. et al. Hedgehog\/Wnt feedback supports regenerative proliferation of epithelial stem cells in bladder. Nature 472, 110\u2013114 (2011).","journal-title":"Nature"},{"key":"1066_CR30","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1002\/cm.10077","volume":"53","author":"P Veranic","year":"2002","unstructured":"Veranic, P. & Jezernik, K. Trajectorial organisation of cytokeratins within the subapical region of umbrella cells. Cell Motil. Cytoskeleton 53, 317\u2013325 (2002).","journal-title":"Cell Motil. Cytoskeleton"},{"key":"1066_CR31","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1038\/ki.2009.73","volume":"75","author":"XR Wu","year":"2009","unstructured":"Wu, X. R., Kong, X. P., Pellicer, A., Kreibich, G. & Sun, T. T. Uroplakins in urothelial biology, function, and disease. Kidney Int. 75, 1153\u20131165 (2009).","journal-title":"Kidney Int."},{"key":"1066_CR32","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jfma.2012.03.010","volume":"113","author":"JD Lee","year":"2014","unstructured":"Lee, J. D. & Lee, M. H. Decreased expression of zonula occludens-1 and occludin in the bladder urothelium of patients with interstitial cystitis\/painful bladder syndrome. J. Formos. Med. Assoc. 113, 17\u201322 (2014).","journal-title":"J. Formos. Med. Assoc."},{"key":"1066_CR33","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1046\/j.1432-0436.1999.6520113.x","volume":"65","author":"S Aboseif","year":"1999","unstructured":"Aboseif, S., El-Sakka, A., Young, P. & Cunha, G. Mesenchymal reprogramming of adult human epithelial differentiation. Differentiation 65, 113\u2013118 (1999).","journal-title":"Differentiation"},{"key":"1066_CR34","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1083\/jcb.96.6.1671","volume":"96","author":"BL Neubauer","year":"1983","unstructured":"Neubauer, B. L. et al. Epithelial-mesenchymal interactions in prostatic development.\u00a0II. Biochemical observations of prostatic induction by urogenital sinus mesenchyme in epithelium of the adult rodent urinary bladder. J. Cell Biol. 96, 1671\u20131676 (1983).","journal-title":"J. Cell Biol."},{"key":"1066_CR35","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.diff.2010.02.002","volume":"79","author":"M Cao","year":"2010","unstructured":"Cao, M. et al. Urothelium-derived Sonic hedgehog promotes mesenchymal proliferation and induces bladder smooth muscle differentiation. Differentiation 79, 244\u2013250 (2010).","journal-title":"Differentiation"},{"key":"1066_CR36","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/s41586-019-1154-y","volume":"569","author":"A Ayyaz","year":"2019","unstructured":"Ayyaz, A. et al. Single-cell transcriptomes of the regenerating intestine reveal a revival stem cell. Nature 569, 121\u2013125 (2019).","journal-title":"Nature"},{"key":"1066_CR37","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1126\/science.aar2131","volume":"360","author":"J Park","year":"2018","unstructured":"Park, J. et al. Single-cell transcriptomics of the mouse kidney reveals potential cellular targets of kidney disease. Science 360, 758\u2013763 (2018).","journal-title":"Science"},{"key":"1066_CR38","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/s41586-018-0393-7","volume":"560","author":"DT Montoro","year":"2018","unstructured":"Montoro, D. T. et al. A revised airway epithelial hierarchy includes CFTR-expressing ionocytes. Nature 560, 319\u2013324 (2018).","journal-title":"Nature"},{"key":"1066_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03740-6","volume":"12","author":"X Cheng","year":"2021","unstructured":"Cheng, X. et al. Single-cell analysis reveals urothelial cell heterogeneity and regenerative cues following cyclophosphamide-induced bladder injury. Cell Death Dis. 12, 446 (2021).","journal-title":"Cell Death Dis."},{"key":"1066_CR40","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/bju.12378","volume":"112","author":"D Clouston","year":"2013","unstructured":"Clouston, D. & Lawrentschuk, N. Metaplastic conditions of the bladder. BJU Int. 112, 27\u201331 (2013).","journal-title":"BJU Int."},{"key":"1066_CR41","doi-asserted-by":"publisher","first-page":"4120","DOI":"10.21037\/tau-21-392","volume":"10","author":"XW Jin","year":"2021","unstructured":"Jin, X. W. et al. An experimental model of the epithelial to mesenchymal transition and pro-fibrogenesis in urothelial cells related to bladder pain syndrome\/interstitial cystitis. Transl. Androl. Urol. 10, 4120\u20134131 (2021).","journal-title":"Transl. Androl. Urol."},{"key":"1066_CR42","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1016\/S0002-9440(10)63737-6","volume":"164","author":"CL Varley","year":"2004","unstructured":"Varley, C. L., Stahlschmidt, J., Smith, B., Stower, M. & Southgate, J. Activation of peroxisome proliferator-activated receptor-gamma reverses squamous metaplasia and induces transitional differentiation in normal human urothelial cells. Am. J. Pathol. 164, 1789\u20131798 (2004).","journal-title":"Am. J. Pathol."},{"key":"1066_CR43","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/S0302-2838(02)00358-5","volume":"42","author":"MS Khan","year":"2002","unstructured":"Khan, M. S., Thornhill, J. A., Gaffney, E., Loftus, B. & Butler, M. R. Keratinising squamous metaplasia of the bladder: natural history and rationalization of management based on review of 54 years experience. Eur. Urol. 42, 469\u2013474 (2002).","journal-title":"Eur. Urol."},{"key":"1066_CR44","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1097\/00000478-199612000-00005","volume":"20","author":"RH Young","year":"1996","unstructured":"Young, R. H. & Bostwick, D. G. Florid cystitis glandularis of intestinal type with mucin extravasation: a mimic of adenocarcinoma. Am. J. Surg. Pathol. 20, 1462\u20131468 (1996).","journal-title":"Am. J. Surg. Pathol."},{"key":"1066_CR45","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1242\/jcs.01042","volume":"117","author":"CL Varley","year":"2004","unstructured":"Varley, C. L. et al. Role of PPARgamma and EGFR signalling in the urothelial terminal differentiation programme. J. Cell Sci. 117, 2029\u20132036 (2004).","journal-title":"J. Cell Sci."},{"key":"1066_CR46","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s12079-013-0216-4","volume":"8","author":"SS Islam","year":"2014","unstructured":"Islam, S. S. et al. TGF-\u03b21 induces EMT reprogramming of porcine bladder urothelial cells into collagen producing fibroblasts-like cells in a Smad2\/Smad3-dependent manner. J. Cell Commun. Signal. 8, 39\u201358 (2014).","journal-title":"J. Cell Commun. Signal."},{"key":"1066_CR47","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.juro.2014.03.037","volume":"192","author":"N Iguchi","year":"2014","unstructured":"Iguchi, N., Hou, A., Koul, H. K. & Wilcox, D. T. Partial bladder outlet obstruction in mice may cause E-cadherin repression through hypoxia induced pathway. J. Urol. 192, 964\u2013972 (2014).","journal-title":"J. Urol."},{"key":"1066_CR48","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.eururo.2019.09.006","volume":"77","author":"A Kamoun","year":"2020","unstructured":"Kamoun, A. et al. A consensus molecular classification of muscle-invasive bladder cancer. Eur. Urol. 77, 420\u2013433 (2020).","journal-title":"Eur. Urol."},{"key":"1066_CR49","doi-asserted-by":"publisher","first-page":"S96","DOI":"10.1038\/modpathol.2009.26","volume":"22","author":"MB Amin","year":"2009","unstructured":"Amin, M. B. Histological variants of urothelial carcinoma: diagnostic, therapeutic and prognostic implications. Mod. Pathol. 22, S96\u2013S118 (2009).","journal-title":"Mod. Pathol."},{"key":"1066_CR50","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.3390\/diagnostics14222501","volume":"14","author":"T Cano Barbadilla","year":"2024","unstructured":"Cano Barbadilla, T. et al. The role of immunohistochemistry as a surrogate marker in molecular subtyping and classification of bladder cancer. Diagnostics 14, 2501 (2024).","journal-title":"Diagnostics"},{"key":"1066_CR51","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.ebiom.2016.08.036","volume":"12","author":"V Dadhania","year":"2016","unstructured":"Dadhania, V. et al. Meta-analysis of the luminal and basal subtypes of bladder cancer and the identification of signature immunohistochemical markers for clinical use. EBioMedicine 12, 105\u2013117 (2016).","journal-title":"EBioMedicine"},{"key":"1066_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-66747-7","volume":"10","author":"CC Guo","year":"2020","unstructured":"Guo, C. C. et al. Assessment of luminal and basal phenotypes in bladder cancer. Sci. Rep. 10, 9743 (2020).","journal-title":"Sci. Rep."},{"key":"1066_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05992-x","volume":"9","author":"L Wang","year":"2018","unstructured":"Wang, L. et al. EMT- and stroma-related gene expression and resistance to PD-1 blockade in urothelial cancer. Nat. Commun. 9, 3503 (2018).","journal-title":"Nat. Commun."},{"key":"1066_CR54","doi-asserted-by":"publisher","first-page":"3908","DOI":"10.1158\/1078-0432.CCR-18-3558","volume":"25","author":"J Batista da Costa","year":"2019","unstructured":"Batista da Costa, J. et al. Molecular characterization of neuroendocrine-like bladder cancer. Clin. Cancer Res. 25, 3908\u20133920 (2019).","journal-title":"Clin. Cancer Res."},{"key":"1066_CR55","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/s41585-023-00847-7","volume":"21","author":"CC Guo","year":"2024","unstructured":"Guo, C. C. et al. Molecular profile of bladder cancer progression to clinically aggressive subtypes. Nat. Rev. Urol. 21, 391\u2013405 (2024).","journal-title":"Nat. Rev. Urol."},{"key":"1066_CR56","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/path.6060","volume":"259","author":"J Fontugne","year":"2023","unstructured":"Fontugne, J. et al. Progression-associated molecular changes in basal\/squamous and sarcomatoid bladder carcinogenesis. J. Pathol. 259, 455\u2013467 (2023).","journal-title":"J. Pathol."},{"key":"1066_CR57","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1038\/labinvest.2008.27","volume":"88","author":"T Majewski","year":"2008","unstructured":"Majewski, T. et al. Understanding the development of human bladder cancer by using a whole-organ genomic mapping strategy. Lab. Invest. 88, 694\u2013721 (2008).","journal-title":"Lab. Invest."},{"key":"1066_CR58","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.euf.2019.09.003","volume":"6","author":"N Lobo","year":"2020","unstructured":"Lobo, N. et al. What is the significance of variant histology in urothelial carcinoma? Eur. Urol. Focus 6, 653\u2013663 (2020).","journal-title":"Eur. Urol. Focus"},{"key":"1066_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41388-023-02876-3","volume":"43","author":"M Ramal","year":"2024","unstructured":"Ramal, M., Corral, S., Kalisz, M., Lapi, E. & Real, F. X. The urothelial gene regulatory network: understanding biology to improve bladder cancer management. Oncogene 43, 1\u201321 (2024).","journal-title":"Oncogene"},{"key":"1066_CR60","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1016\/j.cell.2022.04.015","volume":"185","author":"D Yang","year":"2022","unstructured":"Yang, D. et al. Lineage tracing reveals the phylodynamics, plasticity, and paths of tumor evolution. Cell 185, 1905\u20131923 (2022).","journal-title":"Cell"},{"key":"1066_CR61","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.eururo.2016.06.025","volume":"71","author":"Z Yang","year":"2017","unstructured":"Yang, Z. et al. Single-cell sequencing reveals variants in ARID1A, GPRC5A and MLL2 driving self-renewal of human bladder cancer stem cells. Eur. Urol. 71, 8\u201312 (2017).","journal-title":"Eur. Urol."},{"key":"1066_CR62","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202308438","volume":"11","author":"Y Xiao","year":"2024","unstructured":"Xiao, Y. et al. Integrative single cell atlas revealed intratumoral heterogeneity generation from an adaptive epigenetic cell state in human bladder urothelial carcinoma. Adv. Sci. 11, e2308438 (2024).","journal-title":"Adv. Sci."},{"key":"1066_CR63","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1158\/0008-5472.CAN-14-3067","volume":"75","author":"F He","year":"2015","unstructured":"He, F., Melamed, J., Tang, M. S., Huang, C. & Wu, X. R. Oncogenic HRAS activates epithelial-to-mesenchymal transition and confers stemness to p53-deficient urothelial cells to drive muscle invasion of basal subtype carcinomas. Cancer Res. 75, 2017\u20132028 (2015).","journal-title":"Cancer Res."},{"key":"1066_CR64","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.tcb.2020.07.003","volume":"30","author":"B Bakir","year":"2020","unstructured":"Bakir, B., Chiarella, A. M., Pitarresi, J. R. & Rustgi, A. K. EMT, MET, plasticity, and tumor metastasis. Trends Cell Biol. 30, 764\u2013776 (2020).","journal-title":"Trends Cell Biol."},{"key":"1066_CR65","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.semcancer.2023.10.001","volume":"97","author":"M Saitoh","year":"2023","unstructured":"Saitoh, M. Transcriptional regulation of EMT transcription factors in cancer. Semin. Cancer Biol. 97, 21\u201329 (2023).","journal-title":"Semin. Cancer Biol."},{"key":"1066_CR66","doi-asserted-by":"publisher","first-page":"6265","DOI":"10.1158\/1078-0432.CCR-20-4796","volume":"27","author":"H Wang","year":"2021","unstructured":"Wang, H. et al. Single-cell analyses reveal mechanisms of cancer stem cell maintenance and epithelial-mesenchymal transition in recurrent bladder cancer. Clin. Cancer Res. 27, 6265\u20136278 (2021).","journal-title":"Clin. Cancer Res."},{"key":"1066_CR67","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1038\/s42003-023-05668-3","volume":"6","author":"A Biswas","year":"2023","unstructured":"Biswas, A. et al. Transcriptional state dynamics lead to heterogeneity and adaptive tumor evolution in urothelial bladder carcinoma. Commun. Biol. 6, 1292 (2023).","journal-title":"Commun. Biol."},{"key":"1066_CR68","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.cell.2018.03.017","volume":"173","author":"SH Lee","year":"2018","unstructured":"Lee, S. H. et al. Tumor evolution and drug response in patient-derived organoid models of bladder cancer. Cell 173, 515\u2013528 (2018).","journal-title":"Cell"},{"key":"1066_CR69","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1002\/ijc.34715","volume":"154","author":"G Sj\u00f6dahl","year":"2024","unstructured":"Sj\u00f6dahl, G. et al. Metastasis and recurrence patterns in the molecular subtypes of urothelial bladder cancer. Int. J. Cancer 154, 180\u2013190 (2024).","journal-title":"Int. J. Cancer"},{"key":"1066_CR70","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.eururo.2023.03.020","volume":"85","author":"A Cox","year":"2024","unstructured":"Cox, A. et al. Molecular urothelial tumor cell subtypes remain stable during metastatic evolution. Eur. Urol. 85, 328\u2013332 (2024).","journal-title":"Eur. Urol."},{"key":"1066_CR71","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-52915-0","volume":"15","author":"Y Loriot","year":"2024","unstructured":"Loriot, Y. et al. The genomic and transcriptomic landscape of metastastic urothelial cancer. Nat. Commun. 15, 8603 (2024).","journal-title":"Nat. Commun."},{"key":"1066_CR72","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s41586-019-1730-1","volume":"575","author":"N Vasan","year":"2019","unstructured":"Vasan, N., Baselga, J. & Hyman, D. M. A view on drug resistance in cancer. Nature 575, 299\u2013309 (2019).","journal-title":"Nature"},{"key":"1066_CR73","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1158\/0008-5472.CAN-22-2213","volume":"83","author":"J Zhuang","year":"2023","unstructured":"Zhuang, J. et al. Cancer-associated fibroblast-derived miR-146a-5p generates a niche that promotes bladder cancer stemness and chemoresistance. Cancer Res. 83, 1611\u20131627 (2023).","journal-title":"Cancer Res."},{"key":"1066_CR74","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1158\/0008-5472.CAN-17-0836","volume":"78","author":"A Ooki","year":"2018","unstructured":"Ooki, A. et al. YAP1 and COX2 coordinately regulate urothelial cancer stem-like cells. Cancer Res. 78, 168\u2013181 (2018).","journal-title":"Cancer Res."},{"key":"1066_CR75","doi-asserted-by":"publisher","first-page":"e165","DOI":"10.1016\/S1470-2045(14)71180-5","volume":"16","author":"MG Oser","year":"2015","unstructured":"Oser, M. G., Niederst, M. J., Sequist, L. V. & Engelman, J. A. Transformation from non-small-cell lung cancer to small-cell lung cancer: molecular drivers and cells of origin. Lancet Oncol. 16, e165\u2013e172 (2015).","journal-title":"Lancet Oncol."},{"key":"1066_CR76","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1038\/s43018-022-00431-9","volume":"3","author":"S Deng","year":"2022","unstructured":"Deng, S. et al. Ectopic JAK-STAT activation enables the transition to a stem-like and multilineage state conferring AR-targeted therapy resistance. Nat. Cancer 3, 1071\u20131087 (2022).","journal-title":"Nat. Cancer"},{"key":"1066_CR77","doi-asserted-by":"publisher","first-page":"5297","DOI":"10.3390\/cancers13215297","volume":"13","author":"E Lavallee","year":"2021","unstructured":"Lavallee, E., Sfakianos, J. P. & Mulholland, D. J. Tumor heterogeneity and consequences for bladder cancer treatment. Cancers 13, 5297 (2021).","journal-title":"Cancers"},{"key":"1066_CR78","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1159\/000341860","volume":"58","author":"Y Chen","year":"2012","unstructured":"Chen, Y. et al. Twist confers chemoresistance to anthracyclines in bladder cancer through upregulating P-glycoprotein. Chemotherapy 58, 264\u2013272 (2012).","journal-title":"Chemotherapy"},{"key":"1066_CR79","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-55665-1","volume":"16","author":"A Contreras-Sanz","year":"2025","unstructured":"Contreras-Sanz, A. et al. Proteomic profiling identifies muscle-invasive bladder cancers with distinct biology and responses to platinum-based chemotherapy. Nat. Commun. 16, 1240 (2025).","journal-title":"Nat. Commun."},{"key":"1066_CR80","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.annonc.2024.09.008","volume":"36","author":"CS Groeneveld","year":"2025","unstructured":"Groeneveld, C. S. et al. Basal\/squamous and mixed subtype bladder cancers present poor outcomes after neoadjuvant chemotherapy in the VESPER trial. Ann. Oncol. 36, 89\u201398 (2025).","journal-title":"Ann. Oncol."},{"key":"1066_CR81","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.ebiom.2019.10.058","volume":"50","author":"BN Song","year":"2019","unstructured":"Song, B. N. et al. Identification of an immunotherapy-responsive molecular subtype of bladder cancer. EBioMedicine 50, 238\u2013245 (2019).","journal-title":"EBioMedicine"},{"key":"1066_CR82","doi-asserted-by":"publisher","first-page":"S293","DOI":"10.21037\/tau.2019.06.21","volume":"8","author":"T Todenh\u00f6fer","year":"2019","unstructured":"Todenh\u00f6fer, T. & Seiler, R. Molecular subtypes and response to immunotherapy in bladder cancer patients. Transl. Androl. Urol. 8, S293\u2013s295 (2019).","journal-title":"Transl. Androl. Urol."},{"key":"1066_CR83","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12332-0","volume":"10","author":"C Liu","year":"2019","unstructured":"Liu, C. et al. Pparg promotes differentiation and regulates mitochondrial gene expression in bladder epithelial cells. Nat. Commun. 10, 4589 (2019).","journal-title":"Nat. Commun."},{"key":"1066_CR84","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/j.ajpath.2015.01.014","volume":"185","author":"OL Reddy","year":"2015","unstructured":"Reddy, O. L. et al. Loss of FOXA1 drives sexually dimorphic changes in urothelial differentiation and is an independent predictor of poor prognosis in bladder cancer. Am. J. Pathol. 185, 1385\u20131395 (2015).","journal-title":"Am. J. Pathol."},{"key":"1066_CR85","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1177\/0192623308315672","volume":"36","author":"B Chopra","year":"2008","unstructured":"Chopra, B., Hinley, J., Oleksiewicz, M. B. & Southgate, J. Trans-species comparison of PPAR and RXR expression by rat and human urothelial tissues. Toxicol. Pathol. 36, 485\u2013495 (2008).","journal-title":"Toxicol. Pathol."},{"key":"1066_CR86","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/nature03988","volume":"437","author":"G Pascual","year":"2005","unstructured":"Pascual, G. et al. A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma. Nature 437, 759\u2013763 (2005).","journal-title":"Nature"},{"key":"1066_CR87","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26421-6","volume":"12","author":"T Tate","year":"2021","unstructured":"Tate, T. et al. Pparg signaling controls bladder cancer subtype and immune exclusion. Nat. Commun. 12, 6160 (2021).","journal-title":"Nat. Commun."},{"key":"1066_CR88","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.yexcr.2018.05.031","volume":"369","author":"A Hustler","year":"2018","unstructured":"Hustler, A. et al. Differential transcription factor expression by human epithelial cells of buccal and urothelial derivation. Exp. Cell Res. 369, 284\u2013294 (2018).","journal-title":"Exp. Cell Res."},{"key":"1066_CR89","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/nature12965","volume":"507","author":"The Cancer Genome Atlas Research Network.","year":"2014","unstructured":"The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature 507, 315\u2013322 (2014).","journal-title":"Nature"},{"key":"1066_CR90","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.3390\/cells13171506","volume":"13","author":"R Ben-Yishay","year":"2024","unstructured":"Ben-Yishay, R. et al. Class effect unveiled: PPAR\u03b3 agonists and MEK inhibitors in cancer cell differentiation. Cells 13, 1506 (2024).","journal-title":"Cells"},{"key":"1066_CR91","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.cell.2017.09.007","volume":"171","author":"AG Robertson","year":"2017","unstructured":"Robertson, A. G. et al. Comprehensive molecular characterization of muscle-invasive bladder cancer. Cell 171, 540\u2013556 (2017).","journal-title":"Cell"},{"key":"1066_CR92","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1038\/s41388-019-1063-4","volume":"39","author":"V Osei-Amponsa","year":"2020","unstructured":"Osei-Amponsa, V. et al. Hypermethylation of FOXA1 and allelic loss of PTEN drive squamous differentiation and promote heterogeneity in bladder cancer. Oncogene 39, 1302\u20131317 (2020).","journal-title":"Oncogene"},{"key":"1066_CR93","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/s41556-020-0514-z","volume":"22","author":"M Bi","year":"2020","unstructured":"Bi, M. et al. Enhancer reprogramming driven by high-order assemblies of transcription factors promotes phenotypic plasticity and breast cancer endocrine resistance. Nat. Cell Biol. 22, 701\u2013715 (2020).","journal-title":"Nat. Cell Biol."},{"key":"1066_CR94","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1038\/s41586-019-1318-9","volume":"571","author":"EJ Adams","year":"2019","unstructured":"Adams, E. J. et al. FOXA1 mutations alter pioneering activity, differentiation and prostate cancer phenotypes. Nature 571, 408\u2013412 (2019).","journal-title":"Nature"},{"key":"1066_CR95","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.devcel.2024.10.009","volume":"60","author":"K Gillis","year":"2025","unstructured":"Gillis, K. et al. FoxA1\/2-dependent epigenomic reprogramming drives lineage switching in lung adenocarcinoma. Dev. Cell 60, 472\u2013489 (2025).","journal-title":"Dev. Cell"},{"key":"1066_CR96","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecoenv.2020.111693","volume":"208","author":"Q Zhou","year":"2021","unstructured":"Zhou, Q. et al. HER2 overexpression triggers the IL-8 to promote arsenic-induced EMT and stem cell-like phenotypes in human bladder epithelial cells. Ecotoxicol. Environ. Saf. 208, 111693 (2021).","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"1066_CR97","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7150\/ijbs.77181","volume":"19","author":"S Monteiro-Reis","year":"2023","unstructured":"Monteiro-Reis, S. et al. Vimentin epigenetic deregulation in bladder cancer associates with acquisition of invasive and metastatic phenotype through epithelial-to-mesenchymal transition. Int. J. Biol. Sci. 19, 1\u201312 (2023).","journal-title":"Int. J. Biol. Sci."},{"key":"1066_CR98","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1093\/intbio\/zyz021","volume":"11","author":"F Bocci","year":"2019","unstructured":"Bocci, F. et al. NRF2 activates a partial epithelial-mesenchymal transition and is maximally present in a hybrid epithelial\/mesenchymal phenotype. Integr. Biol. 11, 251\u2013263 (2019).","journal-title":"Integr. Biol."},{"key":"1066_CR99","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1038\/s41556-021-00743-5","volume":"23","author":"A Davies","year":"2021","unstructured":"Davies, A. et al. An androgen receptor switch underlies lineage infidelity in treatment-resistant prostate cancer. Nat. Cell Biol. 23, 1023\u20131034 (2021).","journal-title":"Nat. Cell Biol."},{"key":"1066_CR100","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1038\/s41418-019-0466-7","volume":"27","author":"Y Guo","year":"2020","unstructured":"Guo, Y. et al. GABPA is a master regulator of luminal identity and restrains aggressive diseases in bladder cancer. Cell Death Differ. 27, 1862\u20131877 (2020).","journal-title":"Cell Death Differ."},{"key":"1066_CR101","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.1016\/S0022-5347(05)65630-3","volume":"166","author":"JA Tash","year":"2001","unstructured":"Tash, J. A., David, S. G., Vaughan, E. E. & Herzlinger, D. A. Fibroblast growth factor-7 regulates stratification of the bladder urothelium. J. Urol. 166, 2536\u20132541 (2001).","journal-title":"J. Urol."},{"key":"1066_CR102","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.ajpath.2020.12.011","volume":"191","author":"ST Narla","year":"2021","unstructured":"Narla, S. T. et al. Loss of fibroblast growth factor receptor 2 (FGFR2) leads to defective bladder urothelial regeneration after cyclophosphamide injury. Am. J. Pathol. 191, 631\u2013651 (2021).","journal-title":"Am. J. Pathol."},{"key":"1066_CR103","doi-asserted-by":"publisher","first-page":"7412","DOI":"10.1074\/jbc.M110560200","volume":"277","author":"IU Mysorekar","year":"2002","unstructured":"Mysorekar, I. U., Mulvey, M. A., Hultgren, S. J. & Gordon, J. I. Molecular regulation of urothelial renewal and host defenses during infection with uropathogenic Escherichia coli. J. Biol. Chem. 277, 7412\u20137419 (2002).","journal-title":"J. Biol. Chem."},{"key":"1066_CR104","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.chom.2009.04.005","volume":"5","author":"IU Mysorekar","year":"2009","unstructured":"Mysorekar, I. U., Isaacson-Schmid, M., Walker, J. N., Mills, J. C. & Hultgren, S. J. Bone morphogenetic protein 4 signaling regulates epithelial renewal in the urinary tract in response to uropathogenic infection. Cell Host Microbe 5, 463\u2013475 (2009).","journal-title":"Cell Host Microbe"},{"key":"1066_CR105","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.133232","volume":"5","author":"V Paraskevopoulou","year":"2020","unstructured":"Paraskevopoulou, V. et al. Notch controls urothelial integrity in the mouse bladder. JCI Insight 5, e133232 (2020).","journal-title":"JCI Insight"},{"key":"1066_CR106","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1172\/JCI78185","volume":"125","author":"A Maraver","year":"2015","unstructured":"Maraver, A. et al. NOTCH pathway inactivation promotes bladder cancer progression. J. Clin. Invest. 125, 824\u2013830 (2015).","journal-title":"J. Clin. Invest."},{"key":"1066_CR107","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1158\/1078-0432.CCR-15-2360","volume":"22","author":"T Hayashi","year":"2016","unstructured":"Hayashi, T. et al. Not all NOTCH is created equal: the oncogenic role of NOTCH2 in bladder cancer and its implications for targeted therapy. Clin. Cancer Res. 22, 2981\u20132992 (2016).","journal-title":"Clin. Cancer Res."},{"key":"1066_CR108","first-page":"583","volume":"71","author":"J Southgate","year":"1994","unstructured":"Southgate, J., Hutton, K. A., Thomas, D. F. & Trejdosiewicz, L. K. Normal human urothelial cells in vitro: proliferation and induction of stratification. Lab. Invest. 71, 583\u2013594 (1994).","journal-title":"Lab. Invest."},{"key":"1066_CR109","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.devcel.2013.07.017","volume":"26","author":"D Gandhi","year":"2013","unstructured":"Gandhi, D. et al. Retinoid signaling in progenitors controls specification and regeneration of the urothelium. Dev. Cell 26, 469\u2013482 (2013).","journal-title":"Dev. Cell"},{"key":"1066_CR110","doi-asserted-by":"publisher","first-page":"6596","DOI":"10.21037\/tcr.2020.01.06","volume":"9","author":"Y Nagata","year":"2020","unstructured":"Nagata, Y. & Miyamoto, H. The prognostic role of steroid hormone receptor signaling pathways in urothelial carcinoma. Transl. Cancer Res. 9, 6596\u20136608 (2020).","journal-title":"Transl. Cancer Res."},{"key":"1066_CR111","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/s41585-023-00761-y","volume":"20","author":"J Chen","year":"2023","unstructured":"Chen, J. et al. The androgen receptor in bladder cancer. Nat. Rev. Urol. 20, 560\u2013574 (2023).","journal-title":"Nat. Rev. Urol."},{"key":"1066_CR112","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.canlet.2014.03.018","volume":"348","author":"Y Jing","year":"2014","unstructured":"Jing, Y. et al. Activated androgen receptor promotes bladder cancer metastasis via Slug mediated epithelial-mesenchymal transition. Cancer Lett. 348, 135\u2013145 (2014).","journal-title":"Cancer Lett."},{"key":"1066_CR113","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1111\/and.12203","volume":"46","author":"W Jitao","year":"2014","unstructured":"Jitao, W. et al. Androgen receptor inducing bladder cancer progression by promoting an epithelial-mesenchymal transition. Andrologia 46, 1128\u20131133 (2014).","journal-title":"Andrologia"},{"key":"1066_CR114","first-page":"272","volume":"15","author":"JB Seitz","year":"2022","unstructured":"Seitz, J. B. et al. Immunohistochemical analysis of sex hormone receptors in squamous changes of the urothelium. Int. J. Clin. Exp. Pathol. 15, 272\u2013281 (2022).","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"1066_CR115","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.cell.2006.02.041","volume":"125","author":"BE Bernstein","year":"2006","unstructured":"Bernstein, B. E. et al. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 125, 315\u2013326 (2006).","journal-title":"Cell"},{"key":"1066_CR116","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41418-023-01254-6","volume":"32","author":"C Levra Levron","year":"2024","unstructured":"Levra Levron, C. et al. Bridging tissue repair and epithelial carcinogenesis: epigenetic memory and field cancerization. Cell Death Differ. 32, 78\u201389 (2024).","journal-title":"Cell Death Differ."},{"key":"1066_CR117","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1242\/dev.143958","volume":"144","author":"C Guo","year":"2017","unstructured":"Guo, C., Balsara, Z. R., Hill, W. G. & Li, X. Stage- and subunit-specific functions of polycomb repressive complex 2 in bladder urothelial formation and regeneration. Development 144, 400\u2013408 (2017).","journal-title":"Development"},{"key":"1066_CR118","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1126\/science.1076997","volume":"298","author":"R Cao","year":"2002","unstructured":"Cao, R. et al. Role of histone H3 lysine 27 methylation in Polycomb-group silencing. Science 298, 1039\u20131043 (2002).","journal-title":"Science"},{"key":"1066_CR119","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-67850-5","volume":"10","author":"KE van der Vos","year":"2020","unstructured":"van der Vos, K. E. et al. Epigenetic profiling demarcates molecular subtypes of muscle-invasive bladder cancer. Sci. Rep. 10, 10952 (2020).","journal-title":"Sci. Rep."},{"key":"1066_CR120","doi-asserted-by":"publisher","first-page":"3924","DOI":"10.1172\/JCI127961","volume":"129","author":"A Berger","year":"2019","unstructured":"Berger, A. et al. N-Myc-mediated epigenetic reprogramming drives lineage plasticity in advanced prostate cancer. J. Clin. Invest. 129, 3924\u20133940 (2019).","journal-title":"J. Clin. Invest."},{"key":"1066_CR121","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-021-02325-y","volume":"22","author":"T Iyyanki","year":"2021","unstructured":"Iyyanki, T. et al. Subtype-associated epigenomic landscape and 3D genome structure in bladder cancer. Genome Biol. 22, 105 (2021).","journal-title":"Genome Biol."},{"key":"1066_CR122","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1038\/s41388-023-02662-1","volume":"42","author":"H Neyret-Kahn","year":"2023","unstructured":"Neyret-Kahn, H. et al. Epigenomic mapping identifies an enhancer repertoire that regulates cell identity in bladder cancer through distinct transcription factor networks. Oncogene 42, 1524\u20131542 (2023).","journal-title":"Oncogene"},{"key":"1066_CR123","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-015-0144-4","volume":"7","author":"M Aine","year":"2015","unstructured":"Aine, M. et al. Integrative epigenomic analysis of differential DNA methylation in urothelial carcinoma. Genome Med. 7, 23 (2015).","journal-title":"Genome Med."},{"key":"1066_CR124","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1158\/1541-7786.MCR-20-0359","volume":"18","author":"B Bao","year":"2020","unstructured":"Bao, B. et al. Role of TET1 and 5hmC in an obesity-linked pathway driving cancer stem cells in triple-negative breast cancer. Mol. Cancer Res. 18, 1803\u20131814 (2020).","journal-title":"Mol. Cancer Res."},{"key":"1066_CR125","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-75688-0","volume":"10","author":"A Eray","year":"2020","unstructured":"Eray, A., G\u00fcneri, P. Y., Y\u0131lmaz, G., Karak\u00fclah, G. & Erkek-Ozhan, S. Analysis of open chromatin regions in bladder cancer links \u03b2-catenin mutations and Wnt signaling with neuronal subtype of bladder cancer. Sci. Rep. 10, 18667 (2020).","journal-title":"Sci. Rep."},{"key":"1066_CR126","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-017-0024-5","volume":"8","author":"S Ramakrishnan","year":"2017","unstructured":"Ramakrishnan, S. et al. Decitabine, a DNA-demethylating agent, promotes differentiation via NOTCH1 signaling and alters immune-related pathways in muscle-invasive bladder cancer. Cell Death Dis. 8, 3217 (2017).","journal-title":"Cell Death Dis."},{"key":"1066_CR127","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2023.110881","volume":"112","author":"AS Sahib","year":"2023","unstructured":"Sahib, A. S. et al. miRNA\/epithelial-mesenchymal axis (EMT) axis as a key player in cancer progression and metastasis: a focus on gastric and bladder cancers. Cell Signal. 112, 110881 (2023).","journal-title":"Cell Signal."},{"key":"1066_CR128","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s10555-013-9435-7","volume":"32","author":"S Huang","year":"2013","unstructured":"Huang, S. Genetic and non-genetic instability in tumor progression: link between the fitness landscape and the epigenetic landscape of cancer cells. Cancer Metastasis Rev. 32, 423\u2013448 (2013).","journal-title":"Cancer Metastasis Rev."},{"key":"1066_CR129","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.104551","volume":"25","author":"J Bondaruk","year":"2022","unstructured":"Bondaruk, J. et al. The origin of bladder cancer from mucosal field effects. iScience 25, 104551 (2022).","journal-title":"iScience"},{"key":"1066_CR130","doi-asserted-by":"publisher","DOI":"10.1038\/srep11924","volume":"5","author":"J Zhuang","year":"2015","unstructured":"Zhuang, J. et al. TGF\u03b21 secreted by cancer-associated fibroblasts induces epithelial-mesenchymal transition of bladder cancer cells through lncRNA-ZEB2NAT. Sci. Rep. 5, 11924 (2015).","journal-title":"Sci. Rep."},{"key":"1066_CR131","doi-asserted-by":"publisher","first-page":"8105","DOI":"10.1073\/pnas.1221216110","volume":"110","author":"JC Pignon","year":"2013","unstructured":"Pignon, J. C. et al. p63-expressing cells are the stem cells of developing prostate, bladder, and colorectal epithelia. Proc. Natl Acad. Sci. USA 110, 8105\u20138110 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1066_CR132","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1038\/nrurol.2009.201","volume":"6","author":"KJ Aitken","year":"2009","unstructured":"Aitken, K. J. & B\u00e4gli, D. J. The bladder extracellular matrix. Part I: architecture, development and disease. Nat. Rev. Urol. 6, 596\u2013611 (2009).","journal-title":"Nat. Rev. Urol."},{"key":"1066_CR133","first-page":"3119","volume":"23","author":"RE Hurst","year":"2003","unstructured":"Hurst, R. E. et al. Matrix-dependent plasticity of the malignant phenotype of bladder cancer cells. Anticancer Res. 23, 3119\u20133128 (2003).","journal-title":"Anticancer Res."},{"key":"1066_CR134","doi-asserted-by":"publisher","first-page":"431","DOI":"10.3389\/fonc.2018.00431","volume":"8","author":"V Poltavets","year":"2018","unstructured":"Poltavets, V., Kochetkova, M., Pitson, S. M. & Samuel, M. S. The role of the extracellular matrix and its molecular and cellular regulators in cancer cell plasticity. Front. Oncol. 8, 431 (2018).","journal-title":"Front. Oncol."},{"key":"1066_CR135","doi-asserted-by":"publisher","first-page":"17848","DOI":"10.1073\/pnas.1908228116","volume":"116","author":"A Totaro","year":"2019","unstructured":"Totaro, A. et al. Cell phenotypic plasticity requires autophagic flux driven by YAP\/TAZ mechanotransduction. Proc. Natl Acad. Sci. USA 116, 17848\u201317857 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1066_CR136","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1080\/07357907.2023.2237576","volume":"41","author":"N Rastegar-Pouyani","year":"2023","unstructured":"Rastegar-Pouyani, N. et al. The impact of cancer-associated fibroblasts on drug resistance, stemness, and epithelial-mesenchymal transition in bladder cancer: a comparison between recurrent and non-recurrent patient-derived CAFs. Cancer Invest. 41, 656\u2013671 (2023).","journal-title":"Cancer Invest."},{"key":"1066_CR137","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04303-3","volume":"21","author":"Q Ping","year":"2023","unstructured":"Ping, Q. et al. TGF-\u03b21 dominates stromal fibroblast-mediated EMT via the FAP\/VCAN axis in bladder cancer cells. J. Transl. Med. 21, 475 (2023).","journal-title":"J. Transl. Med."},{"key":"1066_CR138","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1016\/j.ccell.2022.11.005","volume":"40","author":"Z Ma","year":"2022","unstructured":"Ma, Z. et al. Interferon-dependent SLC14A1+ cancer-associated fibroblasts promote cancer stemness via WNT5A in bladder cancer. Cancer Cell 40, 1550\u20131565 (2022).","journal-title":"Cancer Cell"},{"key":"1066_CR139","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/j.celrep.2016.04.019","volume":"15","author":"EY Lau","year":"2016","unstructured":"Lau, E. Y. et al. Cancer-associated fibroblasts regulate tumor-initiating cell plasticity in hepatocellular carcinoma through c-Met\/FRA1\/HEY1 signaling. Cell Rep. 15, 1175\u20131189 (2016).","journal-title":"Cell Rep."},{"key":"1066_CR140","first-page":"3482","volume":"15","author":"J Zhu","year":"2018","unstructured":"Zhu, J. et al. HIF-1\u03b1 promotes ZEB1 expression and EMT in a human bladder cancer lung metastasis animal model. Oncol. Lett. 15, 3482\u20133489 (2018).","journal-title":"Oncol. Lett."},{"key":"1066_CR141","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1007\/s11255-023-03900-x","volume":"56","author":"BN Hudson","year":"2024","unstructured":"Hudson, B. N., Purves, J. T., Hughes, F. M. & Nagatomi, J. Enzyme-induced hypoxia leads to inflammation in urothelial cells in vitro. Int. Urol. Nephrol. 56, 1565\u20131575 (2024).","journal-title":"Int. Urol. Nephrol."},{"key":"1066_CR142","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/ncb1691","volume":"10","author":"MH Yang","year":"2008","unstructured":"Yang, M. H. et al. Direct regulation of TWIST by HIF-1alpha promotes metastasis. Nat. Cell Biol. 10, 295\u2013305 (2008).","journal-title":"Nat. Cell Biol."},{"key":"1066_CR143","doi-asserted-by":"publisher","first-page":"827","DOI":"10.2174\/1566524023666230720163448","volume":"24","author":"J Chai","year":"2024","unstructured":"Chai, J., Yin, S., Feng, W., Zhang, T. & Ke, C. The role of hypoxia-inducible factor-1 in bladder cancer. Curr. Mol. Med. 24, 827\u2013834 (2024).","journal-title":"Curr. Mol. Med."},{"key":"1066_CR144","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.7150\/jca.25257","volume":"9","author":"G Zhang","year":"2018","unstructured":"Zhang, G. et al. MCT1 regulates aggressive and metabolic phenotypes in bladder cancer. J. Cancer 9, 2492\u20132501 (2018).","journal-title":"J. Cancer"},{"key":"1066_CR145","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.21037\/tcr.2019.10.23","volume":"8","author":"SQ Wu","year":"2019","unstructured":"Wu, S. Q. et al. MicroRNA-200c affects bladder cancer angiogenesis by regulating the Akt2\/mTOR\/HIF-1 axis. Transl. Cancer Res. 8, 2713\u20132724 (2019).","journal-title":"Transl. Cancer Res."},{"key":"1066_CR146","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ccr.2010.05.024","volume":"18","author":"J Qi","year":"2010","unstructured":"Qi, J. et al. Siah2-dependent concerted activity of HIF and FoxA2 regulates formation of neuroendocrine phenotype and neuroendocrine prostate tumors. Cancer Cell 18, 23\u201338 (2010).","journal-title":"Cancer Cell"},{"key":"1066_CR147","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/iju.13404","volume":"25","author":"D Fang","year":"2018","unstructured":"Fang, D. & Kitamura, H. Cancer stem cells and epithelial-mesenchymal transition in urothelial carcinoma: Possible pathways and potential therapeutic approaches. Int. J. Urol. 25, 7\u201317 (2018).","journal-title":"Int. J. Urol."},{"key":"1066_CR148","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/S0002-9440(10)64033-3","volume":"158","author":"A Ristim\u00e4ki","year":"2001","unstructured":"Ristim\u00e4ki, A. et al. Expression of cyclooxygenase-2 in human transitional cell carcinoma of the urinary bladder. Am. J. Pathol. 158, 849\u2013853 (2001).","journal-title":"Am. J. Pathol."},{"key":"1066_CR149","first-page":"3028","volume":"58","author":"E Okajima","year":"1998","unstructured":"Okajima, E. et al. Chemopreventive effects of nimesulide, a selective cyclooxygenase-2 inhibitor, on the development of rat urinary bladder carcinomas initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine. Cancer Res. 58, 3028\u20133031 (1998).","journal-title":"Cancer Res."},{"key":"1066_CR150","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/165879","volume":"2012","author":"R Thanan","year":"2012","unstructured":"Thanan, R. et al. Nuclear localization of COX-2 in relation to the expression of stemness markers in urinary bladder cancer. Mediators Inflamm. 2012, 165879 (2012).","journal-title":"Mediators Inflamm."},{"key":"1066_CR151","doi-asserted-by":"publisher","first-page":"3135","DOI":"10.1158\/0008-5472.CAN-11-3195","volume":"72","author":"PL Ho","year":"2012","unstructured":"Ho, P. L., Lay, E. J., Jian, W., Parra, D. & Chan, K. S. Stat3 activation in urothelial stem cells leads to direct progression to invasive bladder cancer. Cancer Res. 72, 3135\u20133142 (2012).","journal-title":"Cancer Res."},{"key":"1066_CR152","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-74390-5","volume":"10","author":"R Abd-El-Raouf","year":"2020","unstructured":"Abd-El-Raouf, R. et al. Escherichia coli foster bladder cancer cell line progression via epithelial mesenchymal transition, stemness and metabolic reprogramming. Sci. Rep. 10, 18024 (2020).","journal-title":"Sci. Rep."},{"key":"1066_CR153","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.53381","volume":"9","author":"TD Somerville","year":"2020","unstructured":"Somerville, T. D. et al. Squamous trans-differentiation of pancreatic cancer cells promotes stromal inflammation. eLife 9, e53381 (2020).","journal-title":"eLife"},{"key":"1066_CR154","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.jpurol.2017.08.013","volume":"13","author":"YT Lu","year":"2017","unstructured":"Lu, Y. T., Tingskov, S. J., Djurhuus, J. C., N\u00f8rregaard, R. & Olsen, L. H. Can bladder fibrosis in congenital urinary tract obstruction be reversed? J. Pediatr. Urol. 13, 574\u2013580 (2017).","journal-title":"J. Pediatr. Urol."},{"key":"1066_CR155","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1111\/j.1464-410X.2011.10650.x","volume":"109","author":"SM Biers","year":"2012","unstructured":"Biers, S. M., Venn, S. N. & Greenwell, T. J. The past, present and future of augmentation cystoplasty. BJU Int. 109, 1280\u20131293 (2012).","journal-title":"BJU Int."},{"key":"1066_CR156","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/nrurol.2012.158","volume":"9","author":"T Drewa","year":"2012","unstructured":"Drewa, T., Adamowicz, J. & Sharma, A. Tissue engineering for the oncologic urinary bladder. Nat. Rev. Urol. 9, 561\u2013572 (2012).","journal-title":"Nat. Rev. Urol."},{"key":"1066_CR157","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1097\/MOU.0000000000000223","volume":"25","author":"NA Sopko","year":"2015","unstructured":"Sopko, N. A., Kates, M. & Bivalacqua, T. J. Use of regenerative tissue for urinary diversion. Curr. Opin. Urol. 25, 578\u2013585 (2015).","journal-title":"Curr. Opin. Urol."},{"key":"1066_CR158","doi-asserted-by":"publisher","first-page":"F757","DOI":"10.1152\/ajprenal.00171.2019","volume":"317","author":"AR Jackson","year":"2019","unstructured":"Jackson, A. R. et al. Krt5(+) urothelial cells are developmental and tissue repair progenitors in the kidney. Am. J. Physiol. Ren. Physiol. 317, F757\u2013F766 (2019).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"1066_CR159","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1016\/j.juro.2011.07.031","volume":"186","author":"R Subramaniam","year":"2011","unstructured":"Subramaniam, R., Hinley, J., Stahlschmidt, J. & Southgate, J. Tissue engineering potential of urothelial cells from diseased bladders. J. Urol. 186, 2014\u20132020 (2011).","journal-title":"J. Urol."},{"key":"1066_CR160","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/s41568-019-0196-7","volume":"19","author":"JH Bushweller","year":"2019","unstructured":"Bushweller, J. H. Targeting transcription factors in cancer - from undruggable to reality. Nat. Rev. Cancer 19, 611\u2013624 (2019).","journal-title":"Nat. Rev. Cancer"},{"key":"1066_CR161","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s41573-021-00371-6","volume":"21","author":"M B\u00e9k\u00e9s","year":"2022","unstructured":"B\u00e9k\u00e9s, M., Langley, D. R. & Crews, C. M. PROTAC targeted protein degraders: the past is prologue. Nat. Rev. Drug Discov. 21, 181\u2013200 (2022).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1066_CR162","doi-asserted-by":"publisher","first-page":"4173","DOI":"10.1200\/JCO.23.02733","volume":"42","author":"KL Jhaveri","year":"2024","unstructured":"Jhaveri, K. L. et al. Imlunestrant, an oral selective estrogen receptor degrader, as monotherapy and in combination with targeted therapy in estrogen receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: phase Ia\/Ib EMBER study. J. Clin. Oncol. 42, 4173\u20134186 (2024).","journal-title":"J. Clin. Oncol."},{"key":"1066_CR163","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.annonc.2024.09.005","volume":"36","author":"DE Rathkopf","year":"2025","unstructured":"Rathkopf, D. E. et al. Safety and clinical activity of BMS-986365 (CC-94676), a dual androgen receptor ligand-directed degrader and antagonist, in heavily pretreated patients with metastatic castration-resistant prostate cancer. Ann. Oncol. 36, 76\u201388 (2025).","journal-title":"Ann. Oncol."},{"key":"1066_CR164","doi-asserted-by":"publisher","first-page":"4386","DOI":"10.3390\/cancers14184386","volume":"14","author":"E Dahl","year":"2022","unstructured":"Dahl, E. et al. White paper: mimetics of class 2 tumor suppressor proteins as novel drug candidates for personalized cancer therapy. Cancers 14, 4386 (2022).","journal-title":"Cancers"},{"key":"1066_CR165","doi-asserted-by":"publisher","first-page":"10164","DOI":"10.3390\/ijms231710164","volume":"23","author":"B Hu","year":"2022","unstructured":"Hu, B. et al. Immobilization of Wnt fragment peptides on magnetic nanoparticles or synthetic surfaces regulate Wnt signaling kinetics. Int. J. Mol. Sci. 23, 10164 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"1066_CR166","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/s41585-024-00857-z","volume":"21","author":"S Zhang","year":"2024","unstructured":"Zhang, S. et al. Targeting histone modifiers in bladder cancer therapy - preclinical and clinical evidence. Nat. Rev. Urol. 21, 495\u2013511 (2024).","journal-title":"Nat. Rev. Urol."},{"key":"1066_CR167","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2024.101116","volume":"76","author":"J Guo","year":"2024","unstructured":"Guo, J. et al. A distinct subset of urothelial cells with enhanced EMT features promotes chemotherapy resistance and cancer recurrence by increasing COL4A1-ITGB1 mediated angiogenesis. Drug Resist. Updat. 76, 101116 (2024).","journal-title":"Drug Resist. Updat."},{"key":"1066_CR168","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.euo.2023.02.011","volume":"6","author":"B Caramelo","year":"2023","unstructured":"Caramelo, B., Zagorac, S., Corral, S., Marqu\u00e9s, M. & Real, F. X. Cancer-associated fibroblasts in bladder cancer: origin, biology, and therapeutic opportunities. Eur. Urol. Oncol. 6, 366\u2013375 (2023).","journal-title":"Eur. Urol. Oncol."},{"key":"1066_CR169","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-06138-6","volume":"23","author":"J Li","year":"2025","unstructured":"Li, J. et al. Epithelial cell diversity and immune remodeling in bladder cancer progression: insights from single-cell transcriptomics. J. Transl. Med. 23, 135 (2025).","journal-title":"J. Transl. Med."},{"key":"1066_CR170","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/nrc.2017.103","volume":"18","author":"H de Th\u00e9","year":"2018","unstructured":"de Th\u00e9, H. Differentiation therapy revisited. Nat. Rev. Cancer 18, 117\u2013127 (2018).","journal-title":"Nat. Rev. Cancer"},{"key":"1066_CR171","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1093\/annonc\/mdl074","volume":"17","author":"C Massard","year":"2006","unstructured":"Massard, C., Deutsch, E. & Soria, J. C. Tumour stem cell-targeted treatment: elimination or differentiation. Ann. Oncol. 17, 1620\u20131624 (2006).","journal-title":"Ann. Oncol."},{"key":"1066_CR172","doi-asserted-by":"publisher","first-page":"3545","DOI":"10.1200\/JCO.2012.41.9572","volume":"30","author":"YN Wong","year":"2012","unstructured":"Wong, Y. N. et al. Phase II trial of cetuximab with or without paclitaxel in patients with advanced urothelial tract carcinoma. J. Clin. Oncol. 30, 3545\u20133551 (2012).","journal-title":"J. Clin. Oncol."},{"key":"1066_CR173","doi-asserted-by":"publisher","first-page":"5060","DOI":"10.1158\/1078-0432.CCR-08-2245","volume":"15","author":"L Adam","year":"2009","unstructured":"Adam, L. et al. miR-200 expression regulates epithelial-to-mesenchymal transition in bladder cancer cells and reverses resistance to epidermal growth factor receptor therapy. Clin. Cancer Res. 15, 5060\u20135072 (2009).","journal-title":"Clin. Cancer Res."},{"key":"1066_CR174","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1158\/2159-8290.CD-22-0692","volume":"13","author":"N De Sarkar","year":"2023","unstructured":"De Sarkar, N. et al. Nucleosome patterns in circulating tumor DNA reveal transcriptional regulation of advanced prostate cancer phenotypes. Cancer Discov. 13, 632\u2013653 (2023).","journal-title":"Cancer Discov."},{"key":"1066_CR175","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1172\/JCI131041","volume":"130","author":"H Beltran","year":"2020","unstructured":"Beltran, H. et al. Circulating tumor DNA profile recognizes transformation to castration-resistant neuroendocrine prostate cancer. J. Clin. Invest. 130, 1653\u20131668 (2020).","journal-title":"J. Clin. Invest."},{"key":"1066_CR176","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1007\/s10555-024-10190-x","volume":"43","author":"MA Aziz","year":"2024","unstructured":"Aziz, M. A. Multiomics approach towards characterization of tumor cell plasticity and its significance in precision and personalized medicine. Cancer Metastasis Rev. 43, 1549\u20131559 (2024).","journal-title":"Cancer Metastasis Rev."}],"container-title":["Nature Reviews Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41585-025-01066-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41585-025-01066-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41585-025-01066-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T13:03:11Z","timestamp":1770382991000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41585-025-01066-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,24]]},"references-count":176,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["1066"],"URL":"https:\/\/doi.org\/10.1038\/s41585-025-01066-y","relation":{},"ISSN":["1759-4812","1759-4820"],"issn-type":[{"value":"1759-4812","type":"print"},{"value":"1759-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,24]]},"assertion":[{"value":"30 June 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}